; and . (2) Certification Section 505(q)(1)(H) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(q)(1)(H) ) is amended by striking I further certify that the information upon which I have based the action requested herein first became known to the party on whose behalf this petition is submitted on or about the following date: ____. and inserting I further certify that the information upon which I have based the action requested herein first became known to the party on whose behalf this petition is submitted on or about ____, which date was not more than 60 days before the date of submitting this petition. . (c) Reporting to Congress Section 505(q)(3) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(q)(3) ) is amended— (1) in the matter before subparagraph (A), by striking specifies ; (2) in subparagraphs (A), (B), (C), and (D), by striking the number and inserting specifies the number ; (3) in subparagraph (C), by striking and at the end; (4) in subparagraph (D), by striking the period at the end and inserting ; and ; and (5) by adding at the end the following: (E) (i) lists each petition submitted during such period and, for each, identifies the petitioner; (ii) quantifies the time and resources expended on each such petition; (iii) states the timing of the petition relative to the expiration date of the patents specified in the pending application in the certification under subsection (b)(2)(A) or (j)(2)(A)(vii), as applicable; (iv) quantifies the delay, if any, caused by any such petition on the approval of any application submitted under subsection (b)(2) or (j), including a description of how any such delay is calculated and an estimate of when any delayed approval would have been granted absent the petition; and (v) in cases in which a pending application and a petition with respect to such pending application are disposed of on the same or nearly the same date, states when the Food and Drug Administration would have disposed of the pending application absent the petition. .